One of the big issues I foresee patients running into is that these medicines, the benefit is only sustained while patients are on the medication
Schedule an Appointment Schedule an Appointment for Your Weight Management Needs TESTIMONIALS What Our Client Say About Us I want to give a shout out to Brandace for being so accommodating and supportive
Medical Writing Assistance The authors thank Manthan Mehta, Kumardeep Paul, Syed Rahman, Mansij Biswas, Arpit Jain, Jignesh Ved, from Boehringer Ingelheim (India) medical affairs for providing writing assistance for this manuscript in accordance with Good Publication Practice (GPP3) guidelines ( Authorship All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published
Extended-release (ER) formulations allow once-daily dosing, usually 1,500-2,000 mg with dinner
Injectable formulations such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) have shown remarkable weight loss results in clinical trials, driving unprecedented demand